Abstract
References
Articles referenced by this article (44)
Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
N Engl J Med, (19):1972-1977 2004
MED: 15525722
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Brain, (Pt 9):2648-2658 2015
MED: 26117366
Cerebrospinal fluid biomarkers for Parkinson’s disease—a systematic review
Acta Neurol. Scand. 2016
Increased dimerization of alpha-synuclein in erythrocytes in Gaucher disease and aging.
Neurosci Lett, (2):205-209 2012
MED: 22981881
Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation.
Exp Mol Med, e188 2015
MED: 26427853
Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal.
Neurobiol Aging, (9):1515-1517 2007
MED: 18160183
Potential compensatory responses through autophagic/lysosomal pathways in neurodegenerative diseases.
Autophagy, (3):234-237 2006
MED: 16874061
Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage.
Neurochem Int, (1):1-7 2012
MED: 23099359
Loss of β-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells.
PLoS One, (4):e60674 2013
MED: 23580063
Show 10 more references (10 of 44)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/j.neulet.2016.10.039
Article citations
Plasma lipidomic signatures of dementia with Lewy bodies revealed by machine learning, and compared to alzheimer's disease.
Alzheimers Res Ther, 16(1):226, 15 Oct 2024
Cited by: 0 articles | PMID: 39407312 | PMCID: PMC11476188
Plasma level of alpha-synuclein oligomers as a biomarker for isolated rapid eye movement sleep behavior disorder diagnosis and progression: a prospective cohort study.
Front Neurol, 15:1442173, 23 Aug 2024
Cited by: 0 articles | PMID: 39246606 | PMCID: PMC11377258
GBA1-Associated Parkinson's Disease Is a Distinct Entity.
Int J Mol Sci, 25(13):7102, 28 Jun 2024
Cited by: 0 articles | PMID: 39000225
Review
Expanding the Neurological Phenotype of Anderson-Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism.
Cells, 13(13):1131, 29 Jun 2024
Cited by: 0 articles | PMID: 38994983 | PMCID: PMC11240674
Review Free full text in Europe PMC
Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia.
Metabolites, 14(1):30, 31 Dec 2023
Cited by: 1 article | PMID: 38248833 | PMCID: PMC10819534
Go to all (38) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Brain, 138(pt 9):2648-2658, 27 Jun 2015
Cited by: 206 articles | PMID: 26117366 | PMCID: PMC4564023
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
J Neurosci, 37(40):9617-9631, 28 Aug 2017
Cited by: 131 articles | PMID: 28847804 | PMCID: PMC5628407
Plasma oligomeric alpha-synuclein is associated with glucocerebrosidase activity in Gaucher disease.
Mov Disord, 30(7):989-991, 12 May 2015
Cited by: 17 articles | PMID: 25962734
Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications.
Neuroscientist, 24(5):540-559, 04 Feb 2018
Cited by: 50 articles | PMID: 29400127
Review
Funding
Funders who supported this work.
RFBR
Russian Foundation for Basic Research (RFBR) (1)
Grant ID: 16-04-00764